Clinical Trial Update: Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients

View source ↗

Summary

Completed clinical validation of the T-Track CMV diagnostic kit from Lophius Biosciences in kidney transplant recipients to assess CMV-specific immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• T-Track CMV Kit

Snippet

Sponsor: Lophius Biosciences GmbH | Conditions: Cytomegalovirus, Kidney Transplantation | Status: COMPLETED